Trial Profile
A Phase I, Placebo-Controlled Dose-Ranging Food Effect and Multiple Dose Study of NPI-001 Tablets in Healthy Subjects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs N-acetylcysteine-amide (Primary)
- Indications Retinitis pigmentosa
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Nacuity Pharmaceuticals
- 14 Jun 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 20 Jun 2018 New trial record